CCR2 and neoplasm: Tumor-resident mesenchymal stem cells, known for their significant secretion of a variety of chemokines, including CCL-2, CCL-7 and CCL-12, enhance the recruitment of CCR2-expressing monocytes to tumor sites, thereby increasing the macrophage population.